SynOx Therapeutics
Sarah Clare is currently the Senior Vice President Finance and Operations at SynOx Therapeutics since July 2021. Prior to this, Sarah held the positions of Director of Finance and Compliance, Financial Controller at e-therapeutics PLC from October 2017 to June 2021. Sarah also worked at Unipart Group from October 2012 to October 2017 as a Group Financial Planner. Sarah started their career as a Business Group Senior at Blick Rothenberg from September 2008 to October 2012. Sarah holds a Bachelor of Science (BSc) in Biology with Management from Imperial College London and completed their A levels in Biology, Maths, and English Literature at Abbotsholme.
This person is not in any teams
This person is not in any offices
SynOx Therapeutics
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.